Method of inhibiting neoplastic cells with 4,5-diaminopyrimidine derivatives
US6380206B1 · kind B1 · utility
22Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2001 |
| Grant date | Apr 30, 2002 |
| Priority date | — |
| Expiry date | May 7, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for inhibiting neoplasia, particularly cancerous and precancerous lesions by exposing the affected cells to 4,5-diaminopyrimidine derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.